KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 112 filers reported holding KEROS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,625,024 | -18.5% | 741,061 | +2.8% | 0.17% | -20.1% |
| Q2 2023 | $28,972,231 | -1.1% | 721,061 | -3.2% | 0.21% | +3.0% |
| Q1 2023 | $29,282,543 | -2.6% | 745,057 | +19.0% | 0.20% | 0.0% |
| Q4 2022 | $30,054,982 | +120.8% | 625,914 | +73.0% | 0.20% | +111.5% |
| Q3 2022 | $13,611,000 | +36.2% | 361,789 | 0.0% | 0.10% | +17.1% |
| Q2 2022 | $9,995,000 | -56.3% | 361,789 | -14.0% | 0.08% | -47.4% |
| Q1 2022 | $22,875,000 | +62.3% | 420,670 | +74.6% | 0.16% | +73.3% |
| Q4 2021 | $14,098,000 | +47.9% | 240,946 | 0.0% | 0.09% | +38.5% |
| Q3 2021 | $9,531,000 | +121.3% | 240,946 | +137.6% | 0.06% | +124.1% |
| Q2 2021 | $4,307,000 | – | 101,409 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 321,300 | $12,087,000 | 4.99% |
| First Light Asset Management, LLC | 598,213 | $22,505,000 | 2.28% |
| Nantahala Capital Management | 845,692 | $31,815,000 | 2.06% |
| CHI Advisors LLC | 200,229 | $7,533,000 | 2.03% |
| Fairmount Funds Management LLC | 272,498 | $10,251,000 | 1.80% |
| Altium Capital Management LP | 88,000 | $3,311,000 | 1.21% |
| Orbimed Advisors | 1,679,417 | $63,180,000 | 1.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,819 | $7,781,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,927 | $3,759,000 | 1.07% |
| Soleus Capital Management, L.P. | 146,000 | $5,493,000 | 0.75% |